🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-h...
Status
Completed
Location
HLB Science
Start Date
2023-07-24
Trial ID
NCT07347223
A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV In...
Status
Completed
Location
Nucleus Network Limited
Start Date
2017-12-08
Trial ID
NCT03384290
This is a phase 1/2a double-blinded, placebo-controlled, dose-escalating st...
Status
Recruiting
Location
Liverpool Hospital
Start Date
2024-03-04
Trial ID
NCT06138743
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Quotient Clinical
Start Date
2013-08
Trial ID
NCT01918735
This clinical study is a randomized, double-blind, double-dummy, parallel g...
Status
Suspended
Location
Sun City Clinical Research
Start Date
2022-12-14
Trial ID
NCT05324358
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-01
Trial ID
NCT01506271
Treatments Being Tested
This is a study of HB-202/HB-201 alternating 2-vector therapy with pembroli...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06513884
Treatments Being Tested
This study is designed to measure the effects of LGT209 when given intraven...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-12
Trial ID
NCT01979601